Loading organizations...
Loading organizations...
Drug discovery company developing therapies for respiratory diseases.
Enterprise Therapeutics has raised $78.7M across 4 funding rounds.
Enterprise Therapeutics has raised $78.7M in total across 4 funding rounds.
Enterprise Therapeutics has raised $78.7M in total across 4 funding rounds.
Enterprise Therapeutics's investors include Rob Woodman, Epidarex Capital, Forbion, Novartis, Versant Ventures, David Morris, MD, Alexander Mayweg, Elizabeth Roper, Geert Jan Mulder, Imperial Innovations.
Enterprise Therapeutics has raised $78.7M across 4 funding rounds. Most recently, it raised $33.0M Series B in January 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 30, 2024 | $33.0M Series B | Rob Woodman | Epidarex Capital, Forbion, Novartis, Versant Ventures |
| Apr 12, 2018 | $37.0M Series B | David Morris, MD, Alexander Mayweg | Elizabeth Roper, Geert Jan Mulder |
| Nov 10, 2016 | $5.0M Other Equity | Elizabeth Roper, Rob Woodman | |
| May 19, 2015 | $3.7M Series A Extension | Imperial Innovations | Epidarex Capital |